"Auropharma: Quarterly बीट्स से Rocket राइड, US जेनरिक्स का दमदार प्रदर्शन!"

Detailed Technical Rationale: Daily Overview: Strong Buy (7/9 buy signals): RSI 63.87 neutral-buy, MACD 7.54 Buy, STOCH 87.81 overbought (watch pullback), ADX 48.7 strong trend up; all 12 MAs bullish (price above EMA5-200). Pivot Levels (5-min): Pivot ₹1,090.8, R1 ₹1,103.1–R2 ₹1,123.7–R3 ₹1,136; S1 ₹1,070.2–S2 ₹1,049.6–S3 ₹1,029.9—trading near R1, high volatility expected pre-results. Trend: Uptrend intact above 50-DMA ~₹1,050, recent consolidation from ₹1,200 high; OBV rising confirms volume support. Enter long above ₹1,103 (R1) targeting ₹1,124–₹1,136, SL ₹1,070 (S1); post-results volatility 3-5% likely.

Detailed Technical Rationale: Daily Overview: Strong Buy (7/9 buy signals): RSI 63.87 neutral-buy, MACD 7.54 Buy, STOCH 87.81 overbought (watch pullback), ADX 48.7 strong trend up; all 12 MAs bullish (price above EMA5-200). Pivot Levels (5-min): Pivot ₹1,090.8, R1 ₹1,103.1–R2 ₹1,123.7–R3 ₹1,136; S1 ₹1,070.2–S2 ₹1,049.6–S3 ₹1,029.9—trading near R1, high volatility expected pre-results. Trend: Uptrend intact above 50-DMA ~₹1,050, recent consolidation from ₹1,200 high; OBV rising confirms volume support. Enter long above ₹1,103 (R1) targeting ₹1,124–₹1,136, SL ₹1,070 (S1); post-results volatility 3-5% likely. News Events & Impact: Earnings call Feb 10 (pre-reg Zoom); recent Nuvama Chemicals/Healthcare Day (Jun 25); Investec/Goldman meetings—positive analyst interactions. No major negatives; pipeline oncology/derma updates expected. Impact: Beat = 8-12% rally to ₹1,200+ (R3 ₹1,136 test); miss on margins/US = drop to ₹1,050 support (3-7%).